Mood Disorders News

Alkermes recently announced study results that indicated efficacy and safety of ALKS 5461, a once-daily oral combination of samidorphan and buprenorphine, for major depressive disorder in individuals with inadequate response to antidepressants.

SAN ANTONIO — In a presentation at the U.S. Psychiatric and Mental Health Congress, Rakesh Jain, MD, MPH, of Texas Tech University School of Medicine, and colleagues discussed associations between inflammation and mental health and provided clinicians with anti-inflammatory strategies to include in their mental health practice.

NeuroRx recently announced it received a notice of allowance from the U.S. Patent Office for its filing for the “Composition and Method for Treatment of Depression in Psychosis in Humans” regarding Cyclurad, an investigational treatment regimen for acute suicidal crisis associated with bipolar depression.

Recent findings suggest that the transition from summer time to standard time may increase incidence of depression.

Low vitamin D levels were associated with negative and depressive symptoms among individuals with a history of psychotic episodes, according to data presented at the International Early Psychosis Association meeting.

The NIMH recently announced that Francis McMahon, MD, chief of the Human Genetics Branch at the NIMH, received the 2016 Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavioral Research Foundation.

Behavioral symptoms of individuals with dementia predicted depressive symptoms among caregivers, particularly daughters, suggesting the emotional relationship between daughter and patient mediates the negative effect of behavioral symptoms on caregiver depression.

SAN FRANCISCO — Screening for postpartum depression in a pediatric ED was effective and accepted among mothers of young infants, according to recent study findings presented at the 2016 AAP National Conference and Exhibition.

SAN ANTONIO — Poster data presented here at the U.S. Psychiatric and Mental Health Congress indicated efficacy of NeuroStar transcranial magnetic stimulation for postpartum depression.

SAN ANTONIO — Despite a lacking research base for efficacy of antidepressants for bipolar depression, they are the most commonly used medication class in bipolar illness, according to a presenter here the U.S. Psychiatric and Mental Health Congress.